Home/Filings/4/0000950170-23-066217
4//SEC Filing

Lucchino David L. 4

Accession 0000950170-23-066217

CIK 0001703647other

Filed

Nov 26, 7:00 PM ET

Accepted

Nov 27, 8:48 PM ET

Size

20.7 KB

Accession

0000950170-23-066217

Insider Transaction Report

Form 4
Period: 2023-11-22
Lucchino David L.
DirectorPresident and CEO
Transactions
  • Sale

    Common Stock

    2023-11-22$35.99/sh110$3,95923,196 total
  • Sale

    Common Stock

    2023-11-22$36.74/sh230$8,45022,966 total
  • Sale

    Common Stock

    2023-11-22$37.98/sh614$23,32222,352 total
  • Sale

    Common Stock

    2023-11-22$38.82/sh202$7,84222,150 total
Footnotes (5)
  • [F1]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance restricted stock units, and does not represent a discretionary trade by the Reporting Person.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.26 to $36.06, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
  • [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.40 to $37.20, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
  • [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.52 to $38.35, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.
  • [F5]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.62 to $39.015, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Issuer, any security holder of the Issuer, or the SEC staff upon request.

Issuer

Korro Bio, Inc.

CIK 0001703647

Entity typeother

Related Parties

1
  • filerCIK 0001785288

Filing Metadata

Form type
4
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 8:48 PM ET
Size
20.7 KB